Navigation Links
The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018
Date:9/15/2009

WALTHAM, Mass., Sept. 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the uptake of novel therapies will drive the obesity drug market to increase more than six-fold, from $512 million in 2008 to more than $3.2 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Obesity finds that the high level of unmet need for efficacious and safe weight-loss therapies will propel the uptake of novel therapies and boost diagnosis and drug-treatment rates of obesity in the world's major pharmaceutical markets. According to the report, physician and patient dissatisfaction with the weight-loss efficacy of current market-leading therapies such as Roche's Xenical, GlaxoSmithKline's OTC Alli and Abbott's Meridia has created an environment that is conducive to the rapid uptake of novel agents. The most notable novel therapies that are expected to launch by 2018 include Arena Pharmaceuticals' lorcaserin and Amylin Pharmaceuticals' pramlintide/leptin combination. The combined sales of lorcaserin and pramlintide/leptin will capture 87 percent of the total obesity market in 2018, according to the report.

The report also finds that the absence of cannabinoid receptor-1 antagonists in the marketplace has created enormous opportunity for drugs with other novel mechanisms of action. Owing to safety concerns, the withdrawal of the cannabinoid-1 receptor antagonist rimonabant (Sanofi-Aventis's Acomplia) from the European markets and the compound's failure to gain U.S. regulatory approval has led several major drug companies to discontinue development of obesity drugs in this class.

"Regulatory agencies and physicians have become increasingly concerned about psychiatric side effects following rimonabant's recent with
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
3. Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016
4. Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
5. 2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics
6. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
7. The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market
8. Electronic Medical Record Technology Uptake Faces Challenges
9. Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms
10. Medical Imaging Equipment Finds Significant Uptake in Ghana, Finds Frost & Sullivan
11. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... cancer in California, the percentage undergoing a double mastectomy ... was not associated with a lower risk of death ... in the September 3 issue of JAMA . ... of one breast was associated with a higher risk ... study. , Randomized trials have demonstrated similar survival for ...
(Date:9/2/2014)... can lay the groundwork for their own spread throughout ... send out tumor-welcoming signals, according to a new report ... 2 issue of Nature Communications , the researchers ... of so-called signaling molecules released by breast cancer cells. ... lungs and lymph nodes to produce proteins called CCL5 ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... (PRWEB) September 03, 2014 Operators in ... to millions of people annually, arranging care and counsel ... and private enterprises are expected to derive $39.4 billion ... donations and private income. Over the five years through ... annualised rate of 6.6%, including growth of 4.1% in ...
(Date:9/2/2014)... -- Two new studies further confirm the health benefits ... breast-fed have a lower risk of ear, throat and ... finds a similar trend when it comes to allergies. ... in the immediate newborn period," said Dr. Jennifer Wu, ... City. She was not involved in the new studies. ...
Breaking Medicine News(10 mins):Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... by scientists at Schepens Eye Research Institute may help ... growth factor responsible for creation of new blood vessels, ... scientists mimicked the drugs activity in mice and found ... from leaking from the ventricle into the brain. The ...
... 13 Healthy Coffee,International, Inc. (Pink Sheets: HCFE) ... arm to handle the distribution of Healthy Coffee,drinks ... America and,the world., About Healthy Coffee USA, ... business opportunity component to,Healthy Coffee by providing an ...
... Medical,Affiliates, Inc. (OTC Bulletin Board: UCIA) announced today that ... percent to,$18,259,000 from $17,043,000 for the quarter ended December ... of $381,000 or $.04 per share,for the quarter ended ... share for the quarter ended December 31, 2006. The ...
... Conn., Feb. 13 ,Allscripts, the leading ... solutions that physicians use to improve ... largest primary care medical group in,Connecticut, ... Record (EHR) and,Practice Management (PM) solution ...
... RICHMOND, Va., Feb. 13 A benefit to help ... (VCU) student,Kellie Brown will be held Friday, February 15, ... W. Marshall Street, in Richmond., Kellie Brown was ... appendicitis and an emergency appendectomy had to be,performed. Following ...
... PACS division sign commercial agreement, NEW YORK, ... that it has signed a preliminary agreement with ... ("Toshiba") for,the resale of its MedicRead Colon and ... Corp. is a global leading provider of,diagnostic medical ...
Cached Medicine News:Health News:Healthy Coffee International, Inc. Establishes Healthy Coffee USA, Inc. as Its Marketing Arm 2Health News:UCI Medical Affiliates, Inc. Reports First Quarter Fiscal Year 2008 Results 2Health News:UCI Medical Affiliates, Inc. Reports First Quarter Fiscal Year 2008 Results 3Health News:ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers 2Health News:ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers 3Health News:Local VA Performers Hold February 15 Benefit to Reduce $10,000 in Medical Bills for Former VCU Student Kellie Brown 2Health News:MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsight's Commercial Agreement with Toshiba PACS Division 2Health News:MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsight's Commercial Agreement with Toshiba PACS Division 3
(Date:9/2/2014)... Spanje, September 2, 2014 ... AF Registry bij het ESC CONGRESS 2014 ... patiënten met risico op beroerte in de ... Gegevens van bijna 12.500 patiënten ingeschreven in ... Fibrillation (GARFIELD-AF), een innovatief, onafhankelijk initiatief op ...
(Date:9/2/2014)... , -- GARFIELD-AF ... into treatment and outcomes of patients at risk ... Data from nearly 12,500 patients enrolled ... Fibrillation (GARFIELD-AF), an innovative, independent academic research initiative, ... fibrillation (AF) patients remain sub-optimal despite the transition ...
(Date:9/2/2014)... BARCELONA, Spain , September 2, 2014 ... treatment decisions, including patients, quality of life and treatment ... [ 2 ]   ... ESC Congress 2014, 02 September 2014, ... year results of the PREvention oF thromboembolic events-European Registry ...
Breaking Medicine Technology:Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 2Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 3Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 4Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 5Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 6Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 7Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 8Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 9Gegevens uit wereldwijde atriumfibrillatieregister tonen aan dat antistollingsmiddelen niet optimaal worden gebruikt ter preventie van beroerte 10Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 2One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 3One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 4One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 5One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 6One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 7One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines 8
... , , , , , LOVELAND, Colo. , Feb. 8 Heska Corporation (Nasdaq: ... , , What: Heska Corporation Invites ... Year-End 2009 Earnings Conference Call on the Web, , ... , Where: www.heska.com (click on the Q4 and Year-End 2009 Earnings ...
... DIEGO , Feb. 8 PatientSafe Solutions, Inc., ... that help to eliminate hospital-based medical errors, announced today that ... financing. The financing was led by TPG Biotech, the leading ... TPG Capital. Co-leads for this financing include Camden Partners and ...
Cached Medicine Technology:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2009 Earnings Conference Call Webcast 2PatientSafe Solutions, Inc. Closes $30 Million Financing 2PatientSafe Solutions, Inc. Closes $30 Million Financing 3
... is the world's most extensive collection ... pure titanium and beta-titanium frames with ... corrosion resistance. This coupled with unsurpassed ... collection that is a step above ...
The Aristar collection offers high quality, fashionable eyewear at exceptional pricing. Classic shapes updated with contemporary designs allow both men and women alike to enjoy superior craftsmanship...
... new Eyewear collection is a wonderfully fresh ... in the House of Salvatore Ferragamo.,The creations ... as well as up-dates of four Sole ... reassert themselves in a brilliant show of ...
... eyewear and sunwear, inspired by ... personal style, with long lasting ... the collection include sophistication, elegance ... offer clean modern shapes, classic ...
Medicine Products: